Literature DB >> 12213717

Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodies.

John H T Power1, John M Shannon, Peter C Blumbergs, Wei-Ping Gai.   

Abstract

Nonselenium glutathione peroxidase (NSGP) is a new member of the antioxidant family. Using antibodies to recombinant NSGP we have examined the distribution of this enzyme in normal, Parkinson's disease (PD), and dementia with Lewy body disease (DLB) brains. We have also co-localized this enzyme with alpha-synuclein as a marker for Lewy bodies. In normal brains there was a very low level of NSGP staining in astrocytes. In PD and DLB there were increases in the number and staining intensity of NSGP-positive astrocytes in both gray and white matter. Cell counting of NSGP cells in PD and DLB frontal and cingulated cortices indicated there was 10 to 15 times more positive cells in gray matter and three times more positive cells in white matter than in control cortices. Some neurons were positive for both alpha-synuclein and NSGP in PD and DLB, and double staining indicated that NSGP neurons contained either diffuse cytoplasmic alpha-synuclein deposits or Lewy bodies. In concentric Lewy bodies, alpha-synuclein staining was peripheral whereas NSGP staining was confined to the central core. Immunoprecipitation indicated there was direct interaction between alpha-synuclein and NSGP. These results suggest oxidative stress conditions exist in PD and DLB and that certain cells have responded by up-regulating this novel antioxidant enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213717      PMCID: PMC1867235          DOI: 10.1016/S0002-9440(10)64249-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

Review 1.  Oxidative stress: Protein folding with a novel redox switch.

Authors:  L W Ruddock; P Klappa
Journal:  Curr Biol       Date:  1999-06-03       Impact factor: 10.834

2.  Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration.

Authors:  G P Davey; S Peuchen; J B Clark
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

3.  A novel type of glutathione peroxidase: expression and regulation during wound repair.

Authors:  B Munz; S Frank; G Hübner; E Olsen; S Werner
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

Review 4.  Redox regulation of cellular signalling.

Authors:  H Kamata; H Hirata
Journal:  Cell Signal       Date:  1999-01       Impact factor: 4.315

5.  Phospholipid hydroperoxides are substrates for non-selenium glutathione peroxidase.

Authors:  A B Fisher; C Dodia; Y Manevich; J W Chen; S I Feinstein
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

6.  Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.

Authors:  W S Davidson; A Jonas; D F Clayton; J M George
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

7.  Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.

Authors:  J Zhang; G Perry; M A Smith; D Robertson; S J Olson; D G Graham; T J Montine
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

8.  Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.

Authors:  H Braak; D Sandmann-Keil; W Gai; E Braak
Journal:  Neurosci Lett       Date:  1999-04-09       Impact factor: 3.046

9.  Cloning and expression of rat lung acidic Ca(2+)-independent PLA2 and its organ distribution.

Authors:  T S Kim; C Dodia; X Chen; B B Hennigan; M Jain; S I Feinstein; A B Fisher
Journal:  Am J Physiol       Date:  1998-05

10.  Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

Authors:  P H Jensen; M S Nielsen; R Jakes; C G Dotti; M Goedert
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  25 in total

1.  Loss of NF-kappaB control and repression of Prdx6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor beta signaling.

Authors:  Nigar Fatma; Eri Kubo; Yoshihiro Takamura; Keiichi Ishihara; Claudia Garcia; David C Beebe; Dhirendra P Singh
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

2.  Protective effects of Nigella sativa L. seed extract on lead induced neurotoxicity during development and early life in mouse models.

Authors:  Umer Javed Butt; Syed Adnan Ali Shah; Touqeer Ahmed; Saadia Zahid
Journal:  Toxicol Res (Camb)       Date:  2017-10-05       Impact factor: 3.524

Review 3.  Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities.

Authors:  Aron B Fisher
Journal:  Antioxid Redox Signal       Date:  2011-03-31       Impact factor: 8.401

Review 4.  Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis.

Authors:  Dean L Pountney; Nicolas H Voelcker; Wei Ping Gai
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

5.  Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain.

Authors:  Rachel Lowe; Dean L Pountney; Poul Henning Jensen; Wei Ping Gai; Nicolas H Voelcker
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

6.  Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis.

Authors:  Angelika Kümin; Christine Huber; Thomas Rülicke; Eckhard Wolf; Sabine Werner
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

7.  DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.

Authors:  Chenere P Ramsey; Elpida Tsika; Harry Ischiropoulos; Benoit I Giasson
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

8.  Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage.

Authors:  Rajkumar Tulsawani; Lorena S Kelly; Nigar Fatma; Bhavanaben Chhunchha; Eri Kubo; Anil Kumar; Dhirendra P Singh
Journal:  BMC Neurosci       Date:  2010-10-05       Impact factor: 3.288

9.  Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST.

Authors:  Y Manevich; S I Feinstein; A B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-02       Impact factor: 11.205

10.  Acceleration of the development of Alzheimer's disease in amyloid beta-infused peroxiredoxin 6 overexpression transgenic mice.

Authors:  Hyung-Mun Yun; Peng Jin; Jin-Yi Han; Moon-Soon Lee; Sang-Bae Han; Ki-Wan Oh; Sung-Han Hong; Eun-Yong Jung; Jin Tae Hong
Journal:  Mol Neurobiol       Date:  2013-06-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.